Related references
Note: Only part of the references are listed.Continuous Infusion Vancomycin for Treatment of Methicillin-Resistant Staphylococcus aureus in Cystic Fibrosis Patients
Lela Fung
ANNALS OF PHARMACOTHERAPY (2012)
Vancomycin AUC24/MIC Ratio in Patients with Complicated Bacteremia and Infective Endocarditis Due to Methicillin-Resistant Staphylococcus aureus and Its Association with Attributable Mortality during Hospitalization
Jack Brown et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
The Clinical Significance of Vancomycin Minimum Inhibitory Concentration in Staphylococcus aureus Infections: A Systematic Review and Meta-analysis
S. J. van Hal et al.
CLINICAL INFECTIOUS DISEASES (2012)
Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review
Sepideh Elyasi et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Protective role of curcumin in nephrotoxic oxidative damage induced by vancomycin in rats
Mohamed H. S. Ahmida
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY (2012)
Mitochondrial superoxide production contributes to vancomycin-induced renal tubular cell apoptosis
Yohei Arimura et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Protective effects of thymoquinone on vancomycin-induced nephrotoxicity in rats
F. Basarslan et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2012)
Continuous versus intermittent infusion of vancomycin for the treatment of Gram-positive infections: systematic review and meta-analysis
Maria Adriana Cataldo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Meta-analysis of Randomized Controlled Trials of Vancomycin for the Treatment of Patients With Gram-Positive Infections: Focus on the Study Design
Konstantinos Z. Vardakas et al.
MAYO CLINIC PROCEEDINGS (2012)
Vancomycin-associated nephrotoxicity: a critical appraisal of risk with high-dose therapy
Annie Wong-Beringer et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
Role of the poly(ADP-ribose)polymerase activity in vancomycin-induced renal injury
Selvinaz Dalaklioglu et al.
TOXICOLOGY LETTERS (2010)
Relationship between Initial Vancomycin Concentration-Time Profile and Nephrotoxicity among Hospitalized Patients
Thomas P. Lodise et al.
CLINICAL INFECTIOUS DISEASES (2009)
Therapeutic Monitoring of Vancomycin in Adults Summary of Consensus Recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists
Michael J. Rybak et al.
PHARMACOTHERAPY (2009)
Gene Expression Analysis Reveals New Possible Mechanisms of Vancomycin-Induced Nephrotoxicity and Identifies Gene Markers Candidates
Christine Dieterich et al.
TOXICOLOGICAL SCIENCES (2009)
Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity
Thomas P. Lodise et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Protective effects of caffeic acid phenethyl ester, vitamin C, vitamin E and N-acetylcysteine on vancomycin-induced nephrotoxicity in rats
Sabahattin Ocak et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2007)
The effect of 2,3-dihydroxybenzoic acid and tempol in prevention of vancomycin-induced nephrotoxicity in rats
Bijan Naghibi et al.
TOXICOLOGY (2007)
Decreased renal accumulation and toxicity of a new VCM formulation in rats with chronic renal failure
Naoko Hodoshima et al.
DRUG METABOLISM AND PHARMACOKINETICS (2007)
In vivo evidences suggesting the role of oxidative stress in pathogenesis of vancomycin-induced nephrotoxicity:: Protection by erdosteine
F Öktem et al.
TOXICOLOGY (2005)
Protective effects of different antioxidants and amrinone on vancomycin-induced nephrotoxicity
I Celik et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2005)
Proliferative responses observed following vancomycin treatment in renal proximal tubule epithelial cells
DW King et al.
TOXICOLOGY IN VITRO (2004)
Targeting superoxide dismutase to renal proximal tubule cells attenuates vancomycin-induced nephrotoxicity in rats
Y Nishino et al.
FREE RADICAL RESEARCH (2003)
Once-daily versus twice-daily intravenous administration of vancomycin for infections in hospitalized patients
E Cohen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Inhibition of vancomycin-induced nephrotoxicity by targeting superoxide dismutase to renal proximal tubule cells in the rat
Y Nishino et al.
REDOX REPORT (2002)
Renal transport of antibiotics and nephrotoxicity: a review
V Fanos et al.
JOURNAL OF CHEMOTHERAPY (2001)